Quarterly report pursuant to Section 13 or 15(d)

Business Combination (Tables)

v3.4.0.3
Business Combination (Tables)
3 Months Ended
Mar. 31, 2016
Business Combinations [Abstract]  
Schedule of Business Acquisitions by Acquisition, Consideration Transferred
The aggregate acquisition consideration was $174.0 million, consisting of (in thousands):

Cash consideration
$
96,359

Total share consideration:
 
     Actual number of shares issued
793

     Multiplied by: Ligand closing share price on January 8, 2016
$
97.92

Total share consideration
77,658

Total consideration
$
174,017

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
he acquisition consideration was preliminarily allocated to the acquisition date fair values of acquired assets and assumed liabilities as follows (in thousands):

     Cash and cash equivalents
$
3,504

     Accounts receivable
5

     Income tax receivable
140

     Prepaid expenses and other current assets
2

     Deferred tax liabilities, net
(56,114
)
     Intangible asset with finite life - core technology
167,000

     Liabilities assumed
(1,279
)
     Goodwill
60,759

Total consideration
$
174,017


Schedule of Pro Forma Information
The following table presents supplemental pro forma information for the three months ended March 31, 2016 and March 31, 2015, as if the acquisition of OMT had occurred on January 1, 2015 (in thousands except for EPS):

 
March 31,
March 31,
 
2016
2015
Revenue
$
32,124

$
17,152

Net income
$
8,877

$
(474
)
 
 
 
Basic earnings per share:
$
0.43

$
(0.02
)
Diluted earnings per share:
$
0.40

$
(0.02
)